You have no items in your shopping cart.
Tamarixetin
SKU: orb1297592
Description
Research Area
Cell Biology, Immunology & Inflammation, Infectious Disease & Virology, Metabolism Research, Neuroscience, Protein Biochemistry, Signal Transduction
Images & Validation
−
Key Properties
−| CAS Number | 603-61-2 |
|---|---|
| MW | 316.26 |
| Purity | 99.21% (May vary between batches) |
| Formula | C16H12O7 |
| SMILES | COc1ccc(cc1O)-c1oc2cc(O)cc(O)c2c(=O)c1O |
| Target | Interleukin,ROS,Antibacterial,Akt,p38 MAPK,Immunology/Inflammation related,Apoptosis,Endogenous Metabolite,COX,JNK,Protease |
| Solubility | DMSO:4.4 mg/mL (13.91 mM);10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (3.16 mM) |
Bioactivity
−| Target IC50 | |
|---|---|
| In Vitro |
Storage & Handling
−| Storage | -20°C |
|---|---|
| Expiration Date | 12 months from date of receipt. |
| Disclaimer | For research use only |
Alternative Names
−CDK, 4'-O-Methyl Quercetin, cardiac, Caspase, anti-oxidative, inflammation, Inflammation related, Inflammationrelated, Immunology related, Immunologyrelated, inhibit, hypertrophy, Inhibitor, Endogenous Metabolite, EndogenousMetabolite, quercetin, Sepsis, P-gp, Tamarixetin
Similar Products
−Tamarixetin-3-O-rutinoside [orb2893398]
98.30% (May vary between batches)
20550-05-4
624.55
C28H32O16
10 mg, 50 mg, 25 mg, 5 mg, 1 mgTamarixetin 7-beta-rutinoside [orb3211759]
99.84% (May vary between batches)
14265-53-3
624.54
C28H32O16
10 mg, 5 mg, 25 mg, 50 mg, 1 mgTamarixetin [orb1217827]
>98% (HPLC)
603-61-2
316.27
C16H12O7
5 mg, 10 mg, 25 mg, 50 mg, 200 mg, 500 mg, 1 g, 100 mg

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].
Compound Identifiers
PubChem CID
Key Properties
− No computed properties available.